Stony Brook, NY, United States of America

Michael E Hogan

This inventor holds 3 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Apdn (b.v.1.) 1Nc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael E Hogan. Retrieved from https://idiyas.com/inventor/michael-e-hogan-zm1qtskt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael E. Hogan in Biotechnology

Introduction

Michael E. Hogan is an accomplished inventor based in Stony Brook, NY. With a robust portfolio of three patents, Hogan has made significant contributions to the field of biotechnology, particularly in the diagnosis of infections and the manufacture of viruses utilized in genetic research.

Latest Patents

One of Hogan's latest patents is titled "Method for identifying mastitis-causing microbes." This innovative method enables the identification of mastitis-causing microbes in subjects by analyzing milk samples. The process involves centrifuging the milk sample to form a microbial pellet, from which total nucleic acids are extracted. Subsequently, a microarray analysis of the extracted DNA allows for the identification of the mastitis-causing microbe through hybridization to specific gene probes. This method is crucial for diagnosing bovine mastitis infections in dairy cows, ultimately improving animal health and dairy production efficiency.

In addition to his work in diagnostics, Hogan holds another patent for "Methods and systems of PCR-based recombinant adeno-associated virus manufacture." This invention outlines systems and methods designed to produce recombinant adeno-associated viruses (rAAV) using one or more DNA constructs created through polymerase chain reaction (PCR). This advancement plays a vital role in the development of gene therapy and vaccine technologies.

Career Highlights

Throughout his career, Hogan has been associated with the company Apdn, which is focused on innovative solutions in biotechnology. His efforts have led to the advancement of methodologies that benefit both the scientific community and agricultural practices.

Collaborations

Michael E. Hogan has collaborated with notable colleagues such as Frederick H. Eggers and Melissa R. May. These partnerships have facilitated the sharing of ideas and expertise, further enhancing the quality and impact of their innovations.

Conclusion

Michael E. Hogan's impact on biotechnology through his patents demonstrates his commitment to addressing critical challenges in agriculture and medical science. His work in identifying microbial infections and advancing viral production methods will pave the way for future innovations that improve both animal welfare and healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…